Probiotics as a therapeutic alternative in amoebiasis. Where are we?
Open Access
- 1 October 2024
- journal article
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (10)
Abstract
Entamoeba histolytica is the cause of amoebiasis, a neglected tropical disease and a leading cause of mortality worldwide. The objective of this review is to show the potential of probiotics as a treatment strategy for amoebiasis. A systematic search was conducted using PubMed and Google Scholar with keywords "Entamoeba histolytica", "amoebiasis", and "probiotics." The studies on probiotics for amoebiasis treatment are limited, but some shown promising results. Lactobacillus acidophilus reduced E. histolytica cyst excretion by 79.67% in mice, with a 68.31% efficacy comparable to metronidazole. Bifidobacterium sp. showed 75.63% efficacy in reducing infection severity, higher than metronidazole (67.56%). Lactobacillus salivarius inhibited E. histolytica growth in vitro and provided protection in vivo. Lactobacillus fermentum and L. delbrueckii inhibited E. histolytica proliferation with efficacy ranging from 46.42% to 97.68%, depending on the concentration. Saccharomyces boulardii reduced amoebic dysentery duration by 25% and eliminated parasitic cysts in human stool samples. Lactobacillus casei showed a 100% recovery rate in rats infected with E. histolytica. These findings suggest probiotics have potential as therapeutic agents for amoebiasis, but further research is needed to confirm their effectiveness in animal models and humans.Keywords
This publication has 29 references indexed in Scilit:
- Pathogenicity and virulence of Entamoeba histolytica , the agent of amoebiasisVirulence, 2023
- Amoebic colitis: A case series of a recurring missed diagnosisJGH Open, 2020
- Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countriesInternational Journal of Medical Microbiology, 2020
- Probiotic research priorities for the healthy adult population: A review on the health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12Cogent Food & Agriculture, 2018
- New developments in goblet cell mucus secretion and functionMucosal Immunology, 2015
- Probiotics, prebiotics, and microencapsulation: A reviewCritical Reviews in Food Science and Nutrition, 2015
- Entamoeba histolytica Exacerbates Epithelial Tight Junction Permeability and Proinflammatory Responses in Muc2 MiceThe American Journal of Pathology, 2013
- The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteriaProceedings of the National Academy of Sciences, 2008
- Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gelProceedings of the National Academy of Sciences, 2006
- Problems in Recognition and Diagnosis of Amebiasis: Estimation of the Global Magnitude of Morbidity and MortalityClinical Infectious Diseases, 1986